Prof. Dr. Abdullah Büyükçelik
Medical Oncology
About Abdullah Büyükçelik
Prof. Abdullah Büyükçelik is a medical oncologist with a strong clinical and academic background. He earned his medical degree and completed his associate professorship at Ankara University Faculty of Medicine in 2006. Since 2009 he has been affiliated with Acibadem Health Group, where he combines patient care with ongoing clinical practice and collaboration. He is an active member of several professional organizations, including the Febrile Neutropenia Association, Medical Oncology Group, Internal Medicine Association, Medical Oncology Society, and Ankara Medical Oncology Association. His memberships reflect a commitment to multidisciplinary care, oncology research, and improving outcomes for patients with cancer and related complications.
Subspecialties
- Aggressive non-Hodgkin lymphoma
- Extranodal Hodgkin lymphoma
- Sarcoma
- Advanced gastric adenocarcinoma
- Advanced pancreatic cancer
- Lung cancer metastases
- Febrile neutropenia
- Chemotherapy-induced nausea and vomiting
- Chemotherapy
- Second-line chemotherapy
- Adjuvant chemotherapy
- Bone marrow transplantation
Education
- 2006 Ankara University Faculty of Medicine / Associate Professor
- 2001 Ankara University Faculty of Medicine Medical Oncology
- 1996 Ankara University Faculty of Medicine Internal Medicine
- 1984 – 1990 Istanbul University Istanbul Faculty of Medicine
Experience
- 2009 Acibadem Health Group
- 2007 – 2009 Ankara University Faculty of Medicine Department of Medical Oncology / Bone Marrow Transplantation Unit
- 2001 – 2009 Department of Medical Oncology, Ankara University Faculty of Medicine
- 1999 – 2001 Ankara University Faculty of Medicine, Medical Oncology Residency
- 1996 – 1999 Ankara Sevgi Hospital / Internal Medicine Specialist
Professional Memberships
- Febrile Neutropenia Association
- Medical Oncology Group
- Internal Medicine Association
- Medical Oncology Society
- Ankara Medical Oncology Association
Selected Publications
- No abstract available. Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting? Med Hypotheses, 73, 628-629, (2009) Dogan M, Yalcin B, Ozal FG, Buyukcelik A, Utkan G, Icli F, Dogan L.
- Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Med Oncol, 2009 Sep 29 Dincol D, Buyukcelik A, Dogan M, Akbulut H, Samur M, Demirkazik A, Senler FC, Onur H, Icli F.
- Prognostic significance of serum matrix metalloproteinase 9 (MMP-9) levels in patients with sarcomas. Yaman E, Yalcin B, Utkan G, Akbulut H, Isikdogan A, Sencan O, Buyukcelik A, Demirkazik A, Icli F. UHOD, 18, 79-84, (2008)
- The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma. Şencan O, Buyukcelik A, Yalcin B, Boruban M.C, Akbulut H, Demirkazik A, Senler F.C, Onur H, Icli F. Eur J Cancer Care, 17,26-32, (2008)
- Lung cancer metastasis mimicking gluteal abscess. South Med. J, 100, 334-335, (2007) Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A.
- Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Buyukcelik A. J. Surg. Oncol, 95, 507-512, (2007)
- Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. South. Med. J. 99, 1149-1150, (2006) Utkan G, Buyukcelik A, Yalcin B, Tek I, Doruk H, Dincol D, Erekul S, Baykara M.
- Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin. Buyukcelik A, Onur H, Akbulut H, Bulent Y, Ensari A, Utkan G, Onal BS, Icli F. Tumori, 91, 302-308, (2005)
Schedule your appointment with Prof. Dr. Abdullah Büyükçelik
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.